The prevalence of hepatitis C in patients suffering from hepatocellular carcinoma ranges between 20% and 90%, and the relative risk that a patient will be infected patient is 25 times greater than that of the general population.
La prevalencia de hepatitis C en pacientes con hepatocarcinoma oscila entre un 20% y un 90% y el riesgo relativo de un individuo infectado es 25 veces mayor que la población general.